Phase II trial of amsacrine in children with advanced metastatic neuroblastoma.
D000609:Aminoacridines / Q000009:adverse effects / Q000627:therapeutic use*; D000677:Amsacrine; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy* / Q000556:secondary
D000609:Aminoacridines; D000970:Antineoplastic Agents; D000677:Amsacrine